Investors shift focus from gene therapy to lucrative weight-loss drugs

A researcher works in Dr. John Tisdale's lab at the National Institutes of Health after the agency announced a breakthrough in sickle cell anemia research in Bethesda, US on March 11, 2019. — ReutersGene therapy, which promises a possible cure for rare diseases like sickle cell, is...

from The News International - Health https://ift.tt/XMqCI2O

Post a Comment

Previous Post Next Post